Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Benjamin J. Miller"'
Autor:
Amira Zaher, Kranti A. Mapuskar, Michael S. Petronek, Munir R. Tanas, Alexandra L. Isaacson, Rebecca D. Dodd, Mohammed Milhem, Muhammad Furqan, Douglas R. Spitz, Benjamin J. Miller, Robert A. Beardsley, Bryan G. Allen
Publikováno v:
Antioxidants, Vol 13, Iss 5, p 587 (2024)
Soft tissue sarcomas (STSs) are mesenchymal malignant lesions that develop in soft tissues. Despite current treatments, including radiation therapy (RT) and surgery, STSs can be associated with poor patient outcomes and metastatic recurrences. Neoadj
Externí odkaz:
https://doaj.org/article/b0197ae339824cb0bd61d1901b655ed0
Autor:
Taylor J. Reif, Patrick K. Strotman, Stephanie A. Kliethermes, Benjamin J. Miller, Lukas M. Nystrom
Publikováno v:
Journal of Bone Oncology, Vol 12, Iss , Pp 14-18 (2018)
Objectives: Metastatic disease involving the femoral head and neck is often treated with a hemiarthroplasty or total hip arthroplasty (THA) to prevent pathologic fracture but there are no outcome studies demonstrating superiority of one option over t
Externí odkaz:
https://doaj.org/article/e357a2abea52425faae22d630b2014c5
Autor:
Cameron M. Callaghan, M. M. Hasibuzzaman, Samuel N. Rodman, Jessica E. Goetz, Kranti A. Mapuskar, Michael S. Petronek, Emily J. Steinbach, Benjamin J. Miller, Casey F. Pulliam, Mitchell C. Coleman, Varun V. Monga, Mohammed M. Milhem, Douglas R. Spitz, Bryan G. Allen
Publikováno v:
Cancers, Vol 12, Iss 8, p 2258 (2020)
Historically, patients with localized soft tissue sarcomas (STS) of the extremities would undergo limb amputation. It was subsequently determined that the addition of radiation therapy (RT) delivered prior to (neoadjuvant) or after (adjuvant) a limb-
Externí odkaz:
https://doaj.org/article/d9631c13986c43d2908a676f0a138d73
Publikováno v:
Geriatric Orthopaedic Surgery & Rehabilitation, Vol 2 (2011)
Background: Little is known about readmission rates for total hip and total knee arthroplasty (THA and TKA). Our objective was to examine readmission rates and whether hospitals with high and low readmission rates at baseline remain outliers in subse
Externí odkaz:
https://doaj.org/article/3070c268f5f84371b98f8eac71cbb00c
Autor:
Lei Wang, Mohammed Milhem, Sudershan Bhatia, Varun Monga, Benjamin J Miller, Munir Tanas, Sarag Boukhar, Bryan Allen, Carryn Anderson, Laura Stephens, Stacey Hartwig, Steven Varga, Jon Houtman, Weizhou Zhang, Omar Jaber, Jon Thomason, David Kuehn, Maheen Rajput, Catherine Metz, K.D. Zamba, Sarah Mott, Chinemerem Abanonu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Soft-tissue sarcomas (STS) in the extremities and trunk treated with standard-of-care preoperative external beam radiation therapy (EBRT) followed by surgical resection are associated with local and distant relapses. In preclinical studies
Externí odkaz:
https://doaj.org/article/51806d52a3e040b9adbc4e9c741f8baa
Publikováno v:
American journal of clinical oncology. 45(8)
We investigated whether patients receiving surgical treatment for metastatic disease of bone (MDB) at hospitals with higher volume, medical school affiliation, or Commission on Cancer accreditation have superior outcomes.Using the Surveillance, Epide
Publikováno v:
Medical Oncology. 40
Autor:
Arham, Pasha, Jessica, Goetz, Marc, Brouillette, Palani, Permeswaran, Trevor R, Gulbrandsen, Benjamin J, Miller
Publikováno v:
Iowa Orthop J
BACKGROUND: As overall cancer survival continues to improve, the incidence of metastatic lesions to the bone continues to increase. The subsequent skeletal related events that can occur with osseous metastasis can be debilitating. Complete and impend
Publikováno v:
Iowa Orthop J
BACKGROUND: Radiation therapy (RT) is often utilized in cases of high-grade soft tissue sarcoma (STS), but there remain situations where treatment is with surgical excision alone. Our goals were to determine (1) the local recurrence (LR) rate with an
Publikováno v:
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine. 236(9)
Metastatic bone disease (MBD) is often managed by non-specialized orthopedic surgeons who rely on Mirels’ criteria to predict pathologic fracture risk. However, low specificity of Mirels’ criteria implies many lesions are scored at high fracture